Xaira Therapeutics Raises $1 billion Series A
Xaira Therapeutics raised $1B in Series A financing led by ARCH Venture, with participation from ARCH Venture Partners, Foresite Capital. AI-powered drug discovery. The new capital is framed around Discover and develop novel therapeutics with AI.
Series A$1 billionTotal tracked $1 billionSan Francisco, CA
What it does
AI-powered drug discovery. The business sits in Healthcare & Life Sciences, where funded companies are using fresh capital to deepen product coverage, distribution, or operating capacity.
Traction
AI can design molecules no human chemist would ever find. Management framed the new capital around Discover and develop novel therapeutics with AI.
Trend impact
MD-grade thesis held: available source material is not specific enough to support a non-generic investor-economist read without overclaiming.
Funding history
- Recent · Series A · $1 billion · ARCH Venture
Products & services
- The State of AI in Healthcare - Menlo Ventures. 2025 capability
- The State of AI in Healthcare - Menlo Ventures capability
- Menlo Ventures Biotech's top money raisers of 2024 - Fierce Biotech. capability
- Biotech's top money raisers of 2024 - Fierce Biotech capability
- Fierce Biotech How Xaira Therapeutics capability